Latest share tips: Mony Group, Bellway & more

Here's your roundup of the latest share tips. See which companies the experts are buying, selling or holding this week.
Mony Group, Bellway and Gleeson are among the companies under the spotlight this week.
Ready to invest but want to shield your returns from the taxman? Open a Stocks & Shares ISA with Hargreaves Lansdown now.
1. Mony Group – ADD
Symbol: MONY.L
Index: FTSE 100
The tech-led savings platform, which trades as MoneySupermarket, revealed that revenue grew 2% to £439 million for the full year 2024.
Jessica Pok, an analyst at Peel Hunt, has maintained her ‘buy’ rating on the stock and has a target price of 280p.
“In the medium term, further progress has the potential to reduce reliance on marketing and increase margins,” she said.
2. Ashmore – BUY
Symbol: ASHM.L
Index: FTSE 250
The specialist emerging markets manager has maintained an interim dividend per share of 4.8p due to its strong financial position, cash generation and near term outlook.
Rae Maile, an analyst at Panmure Liberum, expects some further outflows this year before a gradual recovery.
“History shows that when flows turn, they turn quickly and materially,” he said. “It is likely to be the same this time too.”
Ready to invest but want to shield your returns from the taxman? Open a Stocks & Shares ISA with Hargreaves Lansdown now
3. Bellway – ADD
Symbol: BWY.L
Index: FTSE 250
The housebuilder saw volumes increase around 12% in the first half of the year, with selling prices broadly flat.
After a subdued autumn, the spring selling season is showing a pick-up and the order book is 30% ahead of last year, according to Sam Cullen, an analyst at Peel Hunt.
“Bellway is seeing an encouraging improvement in levels of demand, though consumers remain sensitive to mortgage rates,” he said.
4. Optima Health – BUY
Symbol: OPT.L
Index: FTSE AIM 100 Index
The occupational health company has signed its first license contract for DART – its Digital Assessment Routing Tool.
The agreement with Mersey and West Lancashire Teaching Hospitals NHS Trust follows a four-month pilot study, according to Julie Simmonds, research analyst at Panmure Liberum.
“We see DART as having the potential for significant upside, and a wider rollout remains as upside to our estimates,” she said.
5. Gleeson – BUY
Symbol: GLE.L
Index: FTSE All-Share
The housebuilder delivered a 4% increase in first-half revenue of £158 million and has enjoyed a solid start to the second period.
The reservation rate is 45% ahead of the previous year – helped by the market and the company’s own actions, according to Sam Cullen, an analyst at Peel Hunt.
“Gleeson is operating in an attractive segment of the market, and we expect it to maintain a good sales rate through the balance of the year,” he said.
Ready to invest but want to shield your returns from the taxman? Open a Stocks & Shares ISA with Hargreaves Lansdown now
The information included in this article does not constitute regulated financial advice. You should seek independent, professional financial advice before making any investment decision.
Comments
Do you want to comment on this article? You need to be signed in for this feature